While CD8+ T cells have been used in clinic as effector cells to treat cancer and infectious diseases (NCT00791037, NCT01325636, NCT01475058, NCT00110578), CD8+ Tregs have never been used as suppressive cells to treat autoimmune diseases or to control transplant rejection. The gene discussed is CD8A; the disease is cancer.